Medicalsystem Biotechnology Co., Ltd (SHE:300439)
10.12
+0.15 (1.50%)
May 19, 2026, 10:15 AM CST
SHE:300439 Market Cap
SHE:300439 has a market cap or net worth of 3.83 billion as of May 18, 2026. Its market cap has decreased by -12.61% in one year.
Market Cap
3.83B
Enterprise Value
3.04B
Revenue
1.54B
Ranking
n/a
PE Ratio
58.98
Stock Price
10.12
Market Cap Chart
Since April 22, 2015, SHE:300439's market cap has decreased from 4.49B to 3.83B, a decrease of -14.65%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 3.83B | 1.22% |
| Dec 31, 2025 | 3.79B | -5.65% |
| Dec 31, 2024 | 4.01B | -9.77% |
| Dec 29, 2023 | 4.45B | -0.77% |
| Dec 30, 2022 | 4.48B | -45.10% |
| Dec 31, 2021 | 8.16B | 30.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.55B |
| Amoy Diagnostics | 7.49B |
| Maccura Biotechnology Co.Ltd | 6.20B |
| Cowealth Medical China | 5.70B |
| Thalys Medical Technology Group | 4.40B |
| Shanghai Labway Clinical Laboratory | 4.26B |
| Guangdong Hybribio Biotech | 3.99B |
| SMO ClinPlus CO.,LTD. | 3.78B |